Search

We interviewed Lidya Domínguez, Director of Clinical Research at Sermes CRO, experts in European clinical trial regulation and CTIS, who have been involved in its development since 2017 as members of

Out of the 930 studies authorized by the AEMPS last year, a total of 52 focused on advanced therapy medicines.

"2025 is a turning point for Almirall as we are entering an era of sustained double-digit growth of our net sales CAGR to 2030, and increased EBITDA margins to around 25% by 2028," stated Carlos

Although respiratory diseases are generally not severe, they cause thousands of hospitalizations and deaths worldwide every year, which would increase dramatically if surveillance systems were not in

Study conducted under the CRADA agreement between NCI and Oryzon.

The medical costs of Alzheimer's disease in hospital care increased during the study period, with an average annual cost per patient of 4,969 euros.

Among these, the following stand out 8º Sachs Annual Neuroscience Innovation Forum, 14º Annual LifeSci Advisors Corporate Access Event, Invest Securities BioMed Forum 2025, MidCap Event Frankfurt 2025

Meet Grupo AIA, our new member. We spoke with Guillermo Rodriguez Lázaro, Chief Scientific Director.

In Spain, the incidence of sepsis is 212 cases per 100,000 inhabitants per year, with a mortality rate ranging from 15% to 50%, depending on the severity and speed of treatment.

The startup successfully completed the first stage of its seed investment round, raising €960,000 in private capital.

PVpharm presented a poster communication about the Aula de Farmacovigilancia PVpharm Universidad de Granada at ISoP 23rd annual meeting in Montreal, October 1-5 2024.

Universities interested in joining the 'One University, One Health' initiative are warmly welcome. The current members include the following members: Jaume I University of Castellón, UCAM of Murcia

IQS researchers are designing a new generation of glyconanoparticles functionalized with α-mannose to produce new, more effective vaccines for immunotherapies.

The EASL congress took place between the 5th and the 8th of June in Milan, while the AASLD congress has taken place between the 15th and the 19th of November in San Diego.

Analysis projects 21% annual growth, with global sales expected to reach $39 billion by 2030.

Almirall announces the launch of "The Hive" an innovative scientific research hub, located at Almirall's R&D center in Barcelona, aims to foster collaboration among researchers from biotech companies

GENESIS Biomed, which specialises in consultancy services for early-stage projects in the biomedical sector, will close 2024 with an accumulated turnover of 9 million euros since the start of activity

Promega has launched the GloMax® Galaxy Bioluminescence Imager, an innovative tool for visualizing protein dynamics in live cells using NanoLuc® technologies, eliminating the need for fluorescent